Medicure is a pharmaceutical company focused on the development and commercialization of cardiovascular therapeutics for the U.S. market. Medicure strives to become a leading specialty pharmaceutical company in the U.S. market by improving people's lives through our growing product portfolio of acute cardiovascular products and innovative commercial model.

Medicure Inc. is publicly traded on the Toronto Stock Exchange Venture under the symbol MPH. Its subsidiaries include Medicure International, Inc. (Barbados), which owns the U.S. rights to AGGRASTAT, as well as two U.S. corporations, Medicure USA, Inc. and Medicure Pharma, Inc., which distributes the Company's products in the United States.

Deliverables

Market research
SWOT analysis
Competitive analysis
Website audit
Discovery and strategy
UX/UI design
Web design
Mobile friendly
Content management solution
Web hosting
Technology consulting
Database development
API and systems integration
SEO optimization
Analytics and KPI's

Web Design

Responsive, flexible and robust

Unite Interactive were commissioned to plan, design, and build a responsive, flexible, and robust new website which would help Medicure attract a variety of stakeholders from health professional to investors, raise their profile internationally, and showcase their significant growth and product offerings.

The site needed to provide clear user pathways for very different audiences, while still giving a clear and compelling overview of the company. We worked collaboratively with Medicure's in-house designers, to refine the brand colors, typography, use of imagery, and general design approach.

Not only would Unite Interactive deliver the dynamic, mobile-ready experience Medicure was seeking, its improvements in load speed, flexibility, and security offered the experience and performance goals that were required for the project.

Unite Interactive